J&J in Talks to Buy Guidant - Sources
237836
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson is in negotiations to acquire  medical-device maker Guidant Corp., sources familiar with the  situation said on Tuesday.
329296
Stocks stalled at the open Tuesday as investors shrugged off the impact of weaker crude prices and reports that Johnson &amp; Johnson is seeking to buy Guidant in a $24 billion deal.
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
91019
Johnson &amp; Johnson, the pharmaceutical and health care giant, has announced an agreement to buy Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, for $25.4 billion.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
373656
Johnson &amp; Johnson said late Wednesday that it will buy Guidant Corp. for $23.9 billion in a cash-and-stock deal that had been rumored for weeks.
330580
J.P. Morgan Chase & Co. JPM.N plans  to buy a majority stake in the hedge fund Highbridge Capital  Management, the companies said on Monday, a sign that Wall  Street is seeking a bigger role in the rapidly growing  hedge-fund industry.
148143
Johnson & Johnson JNJ.N has sued   Boston Scientific BSX.N and Abbott Laboratories Inc. ABT.N,   seeking at least $5.5 billion in damages related to J&J's   failed bid to acquire medical device maker Guidant Corp.
340737
Guidant Corp.&#39;s 10-year run as one of Indiana&#39;s most successful public companies will end with a $25 billion sale to health products giant Johnson &amp; Johnson.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
328860
Stocks to watch on Tuesday: JOHNSON &  JOHNSON JNJ.N, GUIDANT CORP. GDT.N
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
177578
Even as the ink dries on Johnson &amp; Johnson&#39;s agreement to buy Guidant Corp. for $25.4 billion, it remains on the hunt for other companies that could bolster
179502
Shares of medical device maker Guidant  Corp.GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.